Intrahippocampal administration of D2 but not D1 dopamine receptor antagonist

suppresses the expression of conditioned place preference induced by morphine

in the ventral tegmental area by Haghparast, Abbas et al.
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Intra-CA1  D2  dopamine  receptors  are  involved  in  the  expression  of  morphine-induced  CPP.
Blockade  of  D1  receptors  in  CA1  had  no effect  on  the  expression  of  morphine-CPP.
Intra-CA1  injection  of  D1/D2  receptor  antagonists  alone  could  not  induce  CPP.
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a  b  s  t  r  a  c  t
The  ventral  tegmental  area  (VTA)  as  a major  source  of  dopamine  neurons  projecting  to cortical  and
limbic  regions  has  a crucial  role  in  reward  and  addiction.  The  current  study  assessed  the  role  of  D1  and
D2 receptors  within  the  dorsal  hippocampus  (CA1)  in  the  expression  of  conditioned  place  preference
(CPP)  by  intra-VTA  morphine  in  the  rats.  In the present  study,  160 adult  male  albino  Wistar  rats  weighing
220–290  g  were  bilaterally  implanted  by  two  cannulae  into  the CA1  and  VTA.  The  CPP  paradigm  was
done  and  animal  displacement,  conditioning  score  and  locomotor  activity  were  recorded.  For  blocking
the dopamine  D1/D2  receptors  in  the  dorsal  hippocampus,  SCH23390  (0.02,  0.05, 0.2  and  0.5 g  per side)
or sulpiride  (0.25,  0.75,  1.5  and  3 g per  side)  were  microinjected  into  the  CA1,  just 5  min  before  the  CPP
test  on  the  post-conditioning  day.  All  animals  received  intra-VTA  morphine  (1  g per side)  during  3-dayspioidergic system
xpression
onditioned place preference
at
conditioning  phase.  Our  results  showed  that  sulpiride  (1.5  and  3 g) but  not  SCH23390  in  the  dorsal
hippocampus  signiﬁcantly  decreased  the  expression  of  CPP  induced  by intra-VTA  morphine  (p  <  0.001).
Intra-CA1  administration  of these  antagonists  alone,  in  all doses,  could  not  induce  CPP. We  suggest  that
D2 receptors  in  the  CA1  region  of  hippocampus  have  a  key  role in  the expression  of CPP  induced  by
morphine  at the  level  of the  VTA  and  there  is a relationship  between  dopaminergic  D2  receptors  and
ese  aopioidergic  systems  in th
. IntroductionIt is now well established that almost all drugs of abuse con-
erge on a common circuitry in the brain which includes the ventral
egmental area (VTA), nucleus accumbens (NAc), hippocampus,
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hypothalamus and prefrontal cortex [15]. The mesolimbic dopami-
nergic system is necessary for the acquisition of morphine-induced
CPP [35,34]. The hippocampus and the VTA form a dopaminer-
gic loop, which may  regulate some kind of information into the
long-term memory that affects hippocampal-dependent learning
[17]. Dopamine D1 receptors have an important role in functional
interaction between the VTA and the hippocampus [22]. Activation
of the VTA increases dopamine (DA) release in the hippocam-
pus and seems to have a pivotal role in hippocampal plasticity
[11,30]. The VTA is an important site for synaptic modiﬁcations
involved in learning and memory to associate morphine exposure
with a speciﬁc environment [9]. It has also been suggested that the
VTA is an important area for reward-related learning [35] through
the dopaminergic projections to the NAc and hippocampus.
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opamine conducts its action by activating two  group-speciﬁc
eceptors, D1-like and D2-like, both of which belong to the family
f G-protein coupled receptors [20]. These two  types of dopamine
eceptor are found in both the hippocampus [20] and the VTA [2].
t has been reported that microinjections of D1 antagonists into
he VTA can disrupt the development of amphetamine sensitiza-
ion, suggesting that DA systems within the midbrain mediate the
euroadaptations that are responsible [32]. Evidently, blockade of
1 receptors disrupts morphine induced conditioned place pref-
rence, whereas such effect is unseen with the D2/D3 receptors
1,16,28]. Moreover, morphine does not induce place preference
n mice lacking D2 receptors [19]. Acute injections of either D1
r D2 receptor antagonists have been reported either not to affect
eroin self-administration or to affect only at doses that also affect
otor function or response rate [31]. Opiates augment DA release
y suppressing GABA inhibitory input to DA neurons in the VTA
9,12].
The hippocampus receives dopaminergic input from the subs-
antia nigra and the VTA [27]. Dopamine receptors in the dorsal
ippocampus have an important role in mediating morphine
eward [24] and the hippocampal CA1 region receives a dopami-
ergic input from the VTA [10,11].  Previous studies showed that the
ippocampus is important for learning tasks, such as conditioned
lace preference (CPP), that use positive reinforcement [13,18,24].
everal studies suggest that both D1- and D2-like receptors in the
A1 region of the dorsal hippocampus are involved in reward-
elated learning and have an important role in the acquisition and
xpression of morphine-induced place preference [24]. In our pre-
ious study, we found that both D1 and D2 receptors have key role
n the development of morphine induced CPP at the level of the VTA
4]. Hence, the aim of this work was to identify the effect of inhi-
ition of the dopamine D1/D2 receptors located in the rat dorsal
ippocampus (CA1) on expression of condition placed preference
ollowed by morphine administration into the ventral tegmental
rea.
. Materials and methods
.1. Animals
One hundred and sixty adult male albino Wistar rats (Pas-
eur Institute, Tehran, Iran) weighting 200–300 g were used in
hese experiments. Animals were caged in group of 3–4 at
3 ± 1 ◦C, 60% humidity, and maintained in a 12-h light/dark
ycle (light on 07:00) with food and water freely available. Each
nimal was used only once. All experiments were executed in
ccordance with the Guide for the Care and Use of Laboratory Ani-
als (National Institute of Health Publication No. 80-23, revised
996).
.2. Stereotaxic surgery
Animals were anesthetized with intraperitoneal injection of
etamine (100 mg/kg) and xylazine (10 mg/kg) and implanted with
wo ipsilateral chronic indwelling guide cannulae, one inside the
TA and one inside the dorsal hippocampus (CA1). These can-
ulae were secured in place using two stainless steel screws
nchored to the skull and dental acrylic cement. The related
oordinates were determined from Paxinos and Watson [33] as
–3.5 mm posterior to the bregma, ±1.8–2 mm  lateral to the mid-
ine, and 2.8–3 mm ventral of the dorsal surface of the skull for
A1 and 4.7–5 mm posterior to the bregma, ±0.8–0.9 mm lat-
ral to the midline and 8.2–8.4 mm  from the top of skull for the
TA (guide cannulae were 1 mm above the appropriate injection
lace). Letters 541 (2013) 138– 143 139
2.3. Drugs
Morphine sulfate was  obtained from TEMAD (Tehran, Iran).
SCH23390 (D1 receptor antagonist) and sulpiride (D2 recep-
tor antagonist) were purchased from Tocris Bioscience (Bristol,
UK). Morphine and SCH23390 were dissolved in physiological
saline and Sulpiride was dissolved in dimethyl sulfoxide (DMSO;
Sigma–Aldrich, Germany). All drugs prepared immediately before
use.
2.4. Conditioning place preference apparatus and paradigm
2.4.1. Apparatus
The testing apparatus consisted of three wooden compart-
ments [3,6,7,21].  Two compartments were identical in size
(30 cm × 30 cm × 40 cm)  but differed in shading and texture. Com-
partment A was  white with black horizontal stripes 2 cm wide
on walls and also had a textured ﬂoor. Compartment B was
black with vertical white stripes 2 cm wide and had a smooth
ﬂoor. The third compartment (C) was a passage painted in red
(30 cm × 15 cm × 40 cm). It protruded from the rear of two  large
compartments and connected the entrances to them.
2.4.2. Behavioral testing
Conditioned place preference consisted of a 5-day schedule
with three phases: pre-conditioning, conditioning and post-
conditioning.
2.4.2.1. Pre-conditioning phase. During this phase (day 1), each ani-
mal  was placed in compartment C with the guillotine door removed
to allow access apparatus for 10 min. In this phase, we  recorded
each animal displacement.
2.4.2.2. Conditioning phase. It consisted of six, 30-min sessions
(three for saline and three drug pairing) in a 3-day schedule. These
sessions were conducted twice each day (from day 2 to day 4) with
a 6-h interval. On each day, separate groups of animals received a
conditioning session with morphine and another received saline.
During 30-min session intervals for morphine/saline, the animals
were conﬁned to one compartment by closing the removable
wall. Treatment compartment and order of presentation of mor-
phine/saline were counterbalanced for either group.
2.4.2.3. Post-conditioning or testing phase. This phase was carried
out on day 5 (the preference test day), 1 day after the last condition-
ing session, in a morphine free state. Each animal was tested only
once. The removable wall was raised and rat could access the entire
apparatus for 10 min. The mean time spent for each rat in both com-
partments during a 10-min period was recorded by a 3CCD camera
(Panasonic Inc., Japan) and analyzed by the Ethovision software
(Version XT7, Noldus Information Technology, the Netherlands) in
order to calculate the conditioning score as the preference crite-
ria; the time spent in the drug-paired place minus the time spent
in saline-paired place. In control and experimental groups, total
distance traveled was also recorded.
2.5. Experimental design
Twenty groups of animals were used (8 rats in each group) in
these experiments. During the conditioning phase animals received
a bilateral microinjection of the morphine sulphate (1 g per 0.3 l
saline) or saline (0.3 l) into the VTA [4].  Later on, 5 min prior
to start of the trial session, different doses of the SCH23390 or
sulpiride were bilaterally microinjected into the CA1 region of hip-
pocampus (0.5 l per side).
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.5.1. Effect of D1 receptor antagonist, SCH23390, pretreatment
n the expression of intra-VTA morphine-induced place preference
In this set of experiments, in order to assess possible effects
f blockade of the D1 receptors in the CA1 on the intra-VTA
orphine induced CPP, we applied different doses of SCH23390
0.02, 0.05, 0.2 and 0.5 g) or saline (0.5 l per side) in morphine-
reated animals on the test day. In saline-treated groups, animals
eceived saline (0.3 l per side) during the conditioning days and
ame doses of SCH23390 or saline were administered prior to test
essions.
.5.2. Effects of D2 receptors antagonist, sulpiride, pretreatment
n the expression of morphine-induced place preference in the VTA
Similar to the aforementioned groups, during the condition-
ng period animals received either morphine sulphate (1 g per
.3 l) or saline (0.3 l) into the VTA and on the test day, differ-
nt doses of sulpiride (0.25, 0.75, 1.5 and 3 g per side) or DMSO
0.5 g per side) as vehicle were microinjected into the CA1 region
f hippocampus.
.6. Statistics
Data are expressed as mean ± SEM (standard error of mean).
ne-way analysis of variance (ANOVA) and randomized blocks
odel followed by post hoc analysis (Newman–Keuls test) were
sed to compare the conditioning scores or locomotor activ-
ty obtained in all control and experimental groups, as needed.
-Values less than 0.05 were considered to be statistically
igniﬁcant.
.7. Histological veriﬁcation
Upon ﬁnishing each experiment, animals were deeply anes-
hetized with ketamine and xylazine. Then, they were transcar-
ially perfused with 0.9% saline and 10% formaldehyde solution
rior to sectioning. The neuroanatomical location of cannulae tips
as conﬁrmed by using the rat brain atlas [33]. The data reported
ere are only from animals in which the placements of cannulae
ips were histologically veriﬁed (Fig. 1A and B).
ig. 1. A photomicrograph of representative (A) morphine microinjection site in the vent
ites  in the nucleus cuneiformis (© = saline microinjection and  = morphine microinjecti
rd  ventricle; D3V, dorsal 3rd ventricle; LV, lateral ventricle; and VTA, ventral tegmental  Letters 541 (2013) 138– 143
3. Results
3.1. Effects of intra-CA1 administration of D1 receptor antagonist,
SCH23390, on the expression of morphine-induced CPP in the VTA
Administration of different doses of SCH23390 (0.02–0.5 g) in
saline- and morphine-treated groups caused no signiﬁcant alter-
ations on the CPP scores in each experimental group. One-way
ANOVA followed by Newman-Keuls test did not indicate any sig-
niﬁcant alterations in CPP scores after SCH23390 administration in
the saline- and morphine-treated groups (Fig. 2A; left and right
panels). One-way ANOVA indicated that none of the groups for
saline- or morphine-treated animals showed signiﬁcant changes
in locomotor activity (Fig. 2B).
3.2. Effects of intra-CA1 administration of D2 receptor antagonist,
sulpiride, on the expression of morphine-induced CPP in the VTA
Fig. 3A (right panel) shows that administration of different
doses of sulpiride (0.25–3 g per side) signiﬁcantly decreased the
conditioning scores in morphine-treated rats. One-way ANOVA fol-
lowed by Newman-Keuls multiple comparison test [F(4,39) = 7.399,
p = 0.0002] indicated that sulpiride in two doses (1.5 and 3 g)
decreases the place preference to morphine microinjected into the
VTA (p < 0.001). Meanwhile, Fig. 3A (left panel) shows that intra-
CA1 administration of sulpiride only, on the test day, was unable
to alter conditioning scores in saline-treated animals. On the other
hand, none of the groups for saline- or morphine-treated animals
revealed signiﬁcant differences in distance traveled (Fig. 3B) dur-
ing 10-min test period. Thus, the different doses of sulpiride used
in this set of experiments did not affect the conditioning scores due
to changes in the locomotor activity on the test day.
4. Discussion
The purpose of this study was  to evaluate the development
of conditioned place preference paradigm after administration of
morphine in ventral tegmental area and the involvement of D1 and
D2 receptors within the hippocampus in the CPP induced by mor-
phine. The major ﬁndings are: (a) Intrahippocampal administration
of D2 receptor antagonist, Sulpiride, suppresses the expression of
ral tegmental area and (B) four coronal schematic sections showing microinjection
on). All microinjections were performed bilaterally (not shown in this picture). 3V,
area. Scale bar is 1 mm.
A. Haghparast et al. / Neuroscience Letters 541 (2013) 138– 143 141
Fig. 2. Intrahippocampal administration of D1 receptor antagonist (SCH23390) in
the  test day had no effect on the conditioning scores (A) and administration of saline
in  the VTA along with SCH23390 in the hippocampus CA1 region failed to induce
conditioned place preference in rats (left). Microinjection of morphine sulphate in
the  VTA in the hippocampus induced conditioned place preference but blockade of
the  D1 receptors (SCH23390) in CA1 region of the hippocampus had no effect on the
conditioning scores (right). (B) Data analysis of the distance traveled by the rat on
the  test day suggests that results were not due to effects on motor activity. Traveled
d
*
C
t
p
v
h
a
d
i
t
r
s
d
r
Fig. 3. Intra-hippocampal administration of D2 receptor antagonist (Sulpiride)
could signiﬁcantly decreased the conditioning scores (A) in the test day. However,
administration of saline into the VTA along with sulpiride in the CA1 region failed
to  induce conditioned place preference in rats (left). Microinjection of morphine
sulphate into the VTA induced conditioned place preference but blockade of the
D2  receptors in CA1 region of the hippocampus signiﬁcantly reduced the condi-
tioning score in two  higher doses (right). (B) Data analysis of the distance traveled
by  the rat on the test day proved that animals had no motor deﬁcit. Points repre-istance is measured on the test day simultaneously by software for 10-min period.
*p  < 0.01 and ***p < 0.001 compared to respective group in saline-treated animals.
PP induced by morphine in the VTA; (b) SCH23390 as a D1 recep-
or antagonism could not suppress the expression of conditioned
lace preference induced by morphine in the VTA. Our data pro-
ided evidence that D2 receptors in the CA1 region of hippocampus
ave a pivotal role in the expression of CPP induced by morphine
t the level of the VTA and it supports the relationship between
opaminergic D2 receptors and opioidergic systems in these areas
n reward circuit. Acquas et al. showed that systemic administra-
ion of dopamine antagonists block the motivational properties of
ewarding as well as aversive stimuli [1].  In line with their work
everal studies have been conducted to clarify the role of different
opamine receptors, especially D1 and D2, in all aspects of reward
elated behaviors. In agreement with our results, Maldonado et al.sent mean ± SEM for 8 animals. **p < 0.01 and ***p < 0.001 compared to respective
group in saline-treated animals. †††p < 0.001 compared to respective control group
in  morphine-treated animals.
indicated that the D2 receptor plays a crucial role in the moti-
vational component of drug addiction [19]. On  the other hand, it
has been shown that the speciﬁc D1 dopamine-receptor antago-
nist SCH2339 blocked the place-preference induced by morphine,
nicotine and diazepam [1].  Our recent study also revealed that D1
and D2 antagonist inhibit the acquisition of morphine induced CPP
[4].
A study on freely moving animals showed that endogenous DA,
which depends on the activity patterns of DA midbrain neurons,
appears as a key regulator in speciﬁc synaptic changes observed
at certain stages of learning and memory and of synaptic plas-
ticity [11]. Also, it has been shown that the VTA is an important
site for synaptic modiﬁcations involved in the learning and mem-
ory of environmental cues predicting reward [8].  Previous studies
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howed that the mesolimbic dopaminergic system that projects
rom the VTA to NAc is critical for initiation of opioid reinforce-
ent [14,25,26] and the reward-related effects of drugs of abuse
5,23]. In 2005, Lisman and Grace supported a model whereby
he hippocampal-VTA loop regulates the entry of information into
ong-term memory, and activation of VTA dopaminergic pathway
o the hippocampus produces an enhancement of LTP and learning
17]. Although hippocampus is known to participate in associative
rocesses such as declarative memory, and not typically consid-
red an integral component of the reward pathway, but it might
e expected to play a signiﬁcant role in the mechanism lead-
ng to development of drug addiction. In fact, the hippocampus
lays an important role in the formation of contextual memory
etween the environment and the rewarding effect of abused drugs.
he dopaminergic neural transmission in the hippocampus seems
o be critical for such memory [24]. Since injection of dopamine
eceptor agents into the hippocampus did not initiate rewarding
ffects, it seems that the hippocampus by itself is not a place of
ewarding but it cooperates with other parts [24]. Hippocampal
xcitatory outputs regulate the activity of VTA dopaminergic neu-
ons through a polysynaptic pathway [5,33].  Moreover, this link
etween hippocampus-dependent memory formation and neuro-
odulation by reward has been conﬁrmed by the fMRI ﬁndings
36].
Recently, Tanaka et al. showed that the protein level of the
opamine D1 receptor and its prerequisite mRNA in the hippocam-
us increases in animals that show a clear preference for the
nvironment paired with cocaine. They concluded that the alter-
tion of dopamine D1receptor in the hippocampus is related to
he induction of drug-induced contextual memory [29]. In addi-
ion results of our previous research showed that administration
f dopamine D1 and D2 receptor antagonists into the CA1 prior
o administration of morphine into the VTA in conditioning phase
nhibit morphine-induced CPP [4].  This ﬁnding have led us to inves-
igate if the memory is formed during conditioning phase, is there
ossibility to be affected by dopamine receptors suppression on the
est day? Our results show that administration of D2 but not D1
eceptor antagonists into the CA1 suppress the expression of CPP
nduced by intra-VTA morphine. In support of our results, Rezayof
nd colleagues showed that blockade of dopamine D1 or D2 recep-
ors in the CA1 region of the dorsal hippocampus abolished the
cquisition and expression of CPP induced by systemic administra-
ion of morphine [24]. Although this research suggests the action
f D1 receptor in the expression of CPP, it cannot be considered
s conﬂicting evidence since morphine was administrated subcu-
aneously. Their ﬁndings may  differ from our results because of
ctivation of opiate receptors outside of the VTA. In conclusion,
lthough there is memory formation during acquisition, memory
etrieval is impaired. It means that animals have a problem in mem-
ry recovery and getting something back. Therefore, we propose
hat D2 but not D1 receptors play an important role in the hip-
ocampus in memory retrieval and development of reward-related
ehaviors. However, further behavioral experiment such as Morris
ater maze and also electrophysiological and molecular investiga-
ions would be necessary to better understanding mechanisms by
hich dopamine receptors within the hippocampus modulate the
esolimbic dopaminergic system in reward circuit.
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